Medication of liver disease can help restore cells affected by dementia. Theoretically, therefore, incurable patients can be a long time to save to the stage where they are still able to live independently.
Researchers from the University of Sheffield in the UK came to the conclusion that is used to treat liver disease drugs can restore cellular damage due to senile dementia. We are talking about drugs based on ursodeoxycholic acid, which reduces mitochondrial dysfunction. This dysfunction is a causal factor both sporadic and hereditary cases of Alzheimer’s disease.
Magicforum recalls that mitochondria play a critical role in cell survival and death, because they regulate energy metabolism and biological pathways of cell death. Mitochondria are like the batteries or the power plants of cells. Quite often in patients with senile dementia found anomalies in mitochondria of many cell types. This deficit develops before the appearance of classical symptoms. In other words, this situation is theoretically possible to take control before people are faced with significant memory loss and becomes completely dependent on others.
Drugs for liver-based ursodeoxycholic acid is currently already applied. They kind of change the shape of mitochondria, and more importantly, these drugs are active in cells from patients with the most common type of senile dementia is a sporadic form that is not related to heredity. And that means that many thousands of patients could theoretically benefit from their use. (READ MORE)